FDA Investigator Ucheabuchi Cchudi Nwankwor

Ucheabuchi Cchudi Nwankwor has conducted inspections on 69 sites in 8 countries as of 22 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
69
Last Inspection Date:
22 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
100001621
Countries of Inspections:
United States of America, Canada, India, Switzerland, Germany, Slovenia, Hungary, Slovakia
FDA Investigators that have inspected at least one site in common with Ucheabuchi Cchudi Nwankwor:
Adam R Cooke, Alan A Rivera, Allison E Sincek, Andrew J Barrowcliff, Andria L Kuhlman, Angela E Glenn, Angelica M Hernandez, Anna M Brannen, Annemarie Kleiza, Anthony J Ladner, Ariel Cruz Figueroa, Arsen Karapetyan, Azza Talaat, Bailey A Uetrecht, Bei Y He, Benjamin D Shuler, Benjamin J Dastoli, Brenda C Hamilton, Brian D Rogers, Bryan L Mcguckin, Bryce A Hammer, Carl A Huffman, III, Carlos H Ruiz, CDR Thomas R Berry, PPh, Charles C Conn, III, Charles D Brown, Charles M Edwards, Chiaochun J Wang, Christina A Miller, Christopher D Snyder, Christopher S Keating, Christopher T Middendorf, Claire M Minden, Cynthia J Lee, MS, Cynthia M Goudeau, Cynthia T Cain, Darla J Christopher, Darren S Brown, Dell S Moller, Denise R Pinkerton, Diane R Mcdaniel, Djamila Harouaka, Doan T Nguyen, PharmD, Donald A Howell, Dorathy M Eischen, Dr. Yubing Tang, Edwin Martinez, Emily E Krumel, Emily J Orban, Evan M Kupper, Felix Maldonado, Fred K Kelly, Frederick M Lochner, Gam S Zamil, Geoffrey K Kilili, Hang N Guo, Holly J Wilson, Hugh M Mcclure, II, Ifueko Osemwota, Isabel Y Espinosa, Ivan E Reyes, Ivy E Sweeney, Janet L Bowen, Jason F Chancey, Javonica F Penn, Jazmine N Still, Jeffery A Hangartner, Jeffrey A Sincek, Jeffrey A Sommers, John A Gonzalez, Jose Acruz Gonzalez, Joshua P Wireman, Joshua S Hunt, Karen M Kondas, Karen M Montgomery (KMM), Katherine D Adams, Kathleen D Culver, Kathryn J Mccarty, Keith J Mason, Jr, Kelli L Wilkinson, Kenneth E Felkley, Kimberly A Joseph, Kirk A Dymbrowski, Lauren N Howard, Lauren N Smith, Laurie B Frazier, LCDR Chad N Thompson, Leslie R Clark, Lindsey M Schwierjohann, Malik S Qaiser, Marianne Allen, Mark E Parmon, Mark G Peterson, Mary E Storch, Matthew B Casale, Matthew H Pitts, Melba Trivera Clavell, Michael D Thatcher, Michael E Campbell, Michael E Clark, Michael K Larson, Michael P Sheehan, Michele L Obert, Mishelle L Harriger, Nadeem I Chaudhry, Nebil A Oumer, Nicholas L Paulin, Noreen Muñiz, Parul M Patel, Patrick C Klotzbuecher, Patrick L Wisor, Philip Kreiter, Phillip M Pontikos, Pifer, Rebecca Rodriguez, Renee N Easter, Robert J Martin, Robert M Barbosa, Robert Rodriguez, Rosanna M Goodrich, Rose Ljean Mary, Rose Xu, Roy C Stephens, Russell J Glapion, Russell K Riley, Sandra A Boyd, Shanna R Haden, Sneha S Patel, Sullan, Susan M Taylor, Tamara M Kays, Ted L Anderson, Tiffani D Wilson, Tracey L Harris, Travis V Hull, Truong Xuan Nguyen (Andy), Tyra S Wisecup, Vipulchandra N Dholakia, Vlada Matusovsky, Wayne D Mcgrath, Wayne W Grundstrom, Yumi J Hiramine, Zachary L Miller, Zhigang Sun, PhD

Ucheabuchi Cchudi Nwankwor's Documents

Publish Date Document Type Title
November, 2017 FDA 483 PakLab - Form 483, 2017-11-30
March, 2019 FDA 483 American Regent, Inc. - Form 483, 2019-03-08
December, 2021 FDA 483 ISP Chemicals LLC - Form 483, 2021-12-10
October, 2023 FDA 483 Alkermes, Inc - Form 483, 2023-10-19
March, 2019 FDA 483 Response American Regent, Inc. - Form 483R, 2019-03-25
February, 2018 FDA 483 Response Safecor Health, LLC - Form 483R, 2018-02-19
February, 2018 FDA 483 Safecor Health, LLC - Form 483, 2018-02-02
July, 2022 FDA 483 BIOCON LIMITED - Form 483, 2022-07-20
June, 2017 FDA 483 American Health Packaging - Form 483, 2017-06-15
May, 2016 FDA 483 Profarma Distribution LLC - Form 483, 2016-05-05
January, 2020 FDA 483 VIVA PHARMACEUTICAL INC. - Form 483, 2020-01-10
June, 2019 FDA 483 Reckitt Benckiser LLC - Form 483, 2019-06-13
November, 2019 EIR West-Ward Columbus Inc. - EIR, 2019-11-22
April, 2017 EIR West-Ward Columbus Inc. - EIR, 2017-04-14
March, 2022 FDA 483 Diamond Wipes International, Inc. - Form 483, 2022-03-03
September, 2018 EIR Integrated Commercialization Solutions, LLC - EIR, 2018-09-13
September, 2022 FDA 483 RC Outsourcing, LLC - Form 483, 2022-09-23
December, 2022 FDA 483 Galentic Pharma (India) Private Limited - Form 483, 2022-12-08
February, 2018 EIR Safecor Health, LLC - EIR, 2018-02-02
July, 2018 EIR Alkermes, Inc - EIR, 2018-07-27
September, 2019 FDA 483 SBH Medical, LTD - Form 483, 2019-09-30
March, 2023 FDA 483 KVP Pharma Veterin Produkte GmbH - Form 483, 2023-03-24
September, 2021 FDA 483 Crosbys Drugs Inc - Form 483, 2021-09-30
January, 2023 FDA 483 V-Ensure Pharma Technologies Pvt Limited - Form 483, 2023-01-27
April, 2018 FDA 483 West-Ward Columbus Inc. - Form 483, 2018-04-18
July, 2023 FDA 483 New Vitalis Pharmacy LLC - Form 483, 2023-07-05
January, 2020 FDA 483 Church & Dwight Canada Corp - Form 483, 2020-01-17
December, 2023 FDA 483 Tri Tech Laboratories, LLC - Form 483, 2023-12-19
July, 2024 FDA 483 US Specialty Formulations LLC - Form 483, 2024-07-02
September, 2024 FDA 483 Pine Pharmaceuticals, LLC - Form 483, 2024-09-30

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more